Published in Biol Blood Marrow Transplant on January 09, 2017
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care (2001) 18.55
The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr (2003) 8.61
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood (1998) 6.72
Bone marrow transplantation for sickle cell disease. N Engl J Med (1996) 4.02
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood (2007) 2.36
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood (2010) 2.15
Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood (2002) 2.02
MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer (2008) 2.01
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood (1995) 1.72
Silent infarcts in young children with sickle cell disease. Br J Haematol (2009) 1.51
Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res (2009) 1.48
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant (2009) 1.46
Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood (2012) 1.37
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant (2007) 1.25
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol (2001) 1.10
Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurol (2013) 1.10
Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol (2002) 1.06
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica (2014) 1.00
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood (2014) 0.96
Central nervous system complications and management in sickle cell disease. Blood (2016) 0.93
Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities. Blood (2016) 0.89
PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer (2013) 0.88
Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol (2005) 0.88
Prognostic Impact of Cerebral Small Vessel Disease on Stroke Outcome. J Stroke (2015) 0.86
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant (2014) 0.85
Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol (2006) 0.83
Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. Br J Haematol (2014) 0.80
Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biol Blood Marrow Transplant (2015) 0.80
White Matter Damage Relates to Oxygen Saturation in Children With Sickle Cell Anemia Without Silent Cerebral Infarcts. Stroke (2015) 0.79
Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant. J Pediatr Hematol Oncol (2014) 0.78
Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia. J Magn Reson Imaging (2014) 0.77
White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging. AJNR Am J Neuroradiol (2012) 0.77
Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia. J Child Neurol (2013) 0.75
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant (2016) 0.79
Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis. Biol Blood Marrow Transplant (2015) 0.79
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Children with Sickle Cell Disease and Thalassemia: a Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant (2017) 0.75
Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes. Biol Blood Marrow Transplant (2016) 0.75